Inhibition of liver prenyltransferase by alkyl phosphonates and phosphonophosphates

Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate

6-Fluoromevalonate blocks the incorporation of mevalonic acid, but not that of isopentenyl pyrophosphate, into non-saponifiable lipids in a rat liver multienzyme system. With 3H-labelled 6-fluoromevalonate, it was found that 6-fluoromevalonate is converted to its phospho and pyrophospho derivatives in this system. The kinetics of the two kinases were studied. 6-Fluoromevalonate 5-pyrophosphate is a potent competitive inhibitor of pyrophosphomevalonate decarboxylase (Ki 37 nM). In the multienzyme assay for cholesterol biosynthesis, there is accumulation of mevalonate 5-phosphate and mevalonate 5-pyrophosphate in the presence of 5 microM-6-fluoromevalonate, and 6-fluoromevalonate 5-pyrophosphate is more effective than 6-fluoromevalonate in inhibiting cholesterol biosynthesis. We suggest therefore that 6-fluoromevalonate blocks cholesterol biosynthesis at the level of pyrophosphomevalonate decarboxylase after being pyrophosphorylated.

Human liver prenyltransferase and its characterization

Prenyltransferase (dimethylallydiphosphate: isopentenyldiphosphate dimethylallytransferase, EC 2.5.1.1) has been purified to homogeneity from human liver obtained at autopsy. The enzyme is a dimer with a native molecular weight of 74 000 +/- 1 400. The amino acid composition is reported. the enzyme has a broad pH optimum between 7.3 and 8.8 and an absolute requirement for either Mn2+ or Mg2+ for activity; half-maximal activity was observed at 3.7 microM Mn2+ or 89.0 microM Mg2+. Michaelis constants for geranyl pyrophosphate and isopentenyl pyrophosphate were 0.44 and 0.94 microM, respectively; the V value for synthesis of farnesyl pyrophosphate from these substrates was 1.1 mumol . min-1 . mg-1. Isopentenyl pyrophosphate inhibited the reaction rates at concentrations above 2 microM when the concentrations of geranyl pyrophosphate were less than 2 microM. The highest concentration of geranyl pyrophosphate tested, 16 microM, showed no inhibition of reaction rates even when the concentration of isopentenyl pyrophosphate was as low as 0.2 microM. Only one form of human liver prenyltransferase could be observed under conditions which resolved the porcine enzyme into two distinct forms; the human enzyme is akin, physico-chemically, to the B-form of the pig liver enzyme. After dialysis against Tris-HCl buffer, pH 7.8, the enzyme became completely dependent upon dithiols or thiols for its activity. Kinetic experiments with a partially activated enzyme sample showed that the activation by the dithiol greatly enhanced the affinity of the enzyme for geranyl pyrophosphate, but not that for isopentenyl pyrophosphate. The human prenyltransferase is inactivated by phenylglyoxal according to pseudo-first-order kinetics, but is protected against the inactivation by 3,3-dimethylallyl and geranyl pyrophosphate. It is also inactivated by high concentrations (greater than 2 mM) of iodoacetic acid, but is protected against the inactivation by dithiothreitol. Antibodies raised to the B-form of the pig liver enzyme cross-reacted with the human prenyltransferase and were 47% as effective in precipitating the human enzyme as the porcine enzyme. In double immunodiffusion experiments the antiserum was monospecific against the B-form of the porcine enzyme; it also gave a single precipitin line with the A-form, but not identical with that given by the B-form. It gave a precipitin line also with the human enzyme, but not identical with that given by either the A- or B-form of the porcine enzyme.

Characterization of liver prenyl transferase and its inactivation by phenylglyoxal

The two interconvertible forms of pig liver prenyl transferase, A and B, consist of two identical subunits of Mr = 38 500 and are dimers. Form A contains six titratable SH-groups, whereas form B contains only four per dimer. The amino acid composition of the two forms is otherwise identical. Both enzyme forms are inactivated by phenylglyoxal. The inactivation in the absence of Mg2+ or Mn2+ is biphasic, each phase following pseudo first-order kinetics and is accompanied by a proportional binding of [14C]phenylglyoxal to the protein. In the initial fast phase of inactivation (t1/2 = 9.6 min) the amount of [14C]phenylglyoxal bound to the enzyme extrapolated to 1.1 arginyl residues and in the second phase (t1/2 = 23 min) to 2.2 arginyl residues modified per subunit for complete inactivation. 1 mM Mg2+ and 0.1 mM Mn2+ abolished the initial fast rate of inactivation and reduced its rate to a single half-life of about 60 min. Even at this slow rate of inactivation in the presence of Mg2+, the amount of [14C]phenylglyoxal bound to the enzyme extrapolated to about 2.3 arginyl residues modified per subunit for complete inactivation. In the absence of Mg2+ or Mn2+ only 1 mM geranyl pyrophosphate protected the enzyme against inactivation. However, in the presence of 1 mM Mg2+, isopentenyl, dimethylallyl and geranyl pyrophosphates gave additional protection over that observed with the metal ions, geranyl pyrophosphate being the most effective at 0.1 mM concentration.